Document is current
Any future updates will be listed below
-
Authors
Chawner, Samuel J. R. A. https://orcid.org/0000-0002-2590-2874
Evans, Alexandra
,
Wolstencroft, Jeanne
Chawner, Samuel J. R. A.
Hall, Jeremy
van den Bree, Marianne B. M.
Owen, Michael J.
Skuse, David
Raymond, F. Lucy
Williams, Nigel
Owen, Michael J. https://orcid.org/0000-0003-4798-0862
Hall, Jeremy https://orcid.org/0000-0002-0403-3278
van den Bree, Marianne B. M. https://orcid.org/0000-0002-4426-3254
-
Funding
Funding for this research was provided by:
RCUK | MRC | Medical Research Foundation (MRF-058-0015-F-CHAW)
Waterloo Foundation (WF918-1234)
Baily Thomas Charitable Fund (2315/1)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (5UO1MH101724)
Wellcome Trust (ISSF Grant)
RCUK | Medical Research Council (MR/L011166/1, MR/N022572/1)
- License Information
-
More Information
Article History
Received: 2 August 2022
Revised: 8 December 2022
Accepted: 21 December 2022
First Online: 11 January 2023
Competing interests
: JH reports grants from Wyeth, grants from Pfizer, grants from Abbvie and grants from A&Z, outside the scope of the submitted work. MJO, JH and MBMvdB report funding grants from Takeda Pharmaceuticals, outside the scope of the submitted work. MJO reports funding from Akrivia Health outside the scope of the submitted work.
